Old medications and new targeted therapies in systemic sclerosis.
about
Current perspectives on the immunopathogenesis of systemic sclerosisSystemic sclerosis: commonly asked questions by rheumatologistsHand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available TreatmentPredictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisTreatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesSystemic sclerosis: a systematic review on therapeutic management from 2011 to 2014.Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.TRPV4 ion channel is a novel regulator of dermal myofibroblast differentiation.Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis.The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisRituximab in early systemic sclerosis.Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis.Rheopheresis as a causal therapy option for systemic scleroderma (SSc).Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials.The new frontier in systemic sclerosis: from epigenetics to new treatments.Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
P2860
Q26741264-0BF2C131-8A63-4F2B-80D2-F6AACCFD3343Q27021067-EB8551A9-876D-43F4-A876-05B8F1074EE5Q34548029-ADB24485-E501-41B8-B550-91B9F2B918E0Q36477472-A007C8B3-9454-4AE6-A0C5-4AF4DDCB835DQ36758822-2740B59E-6149-4788-B15B-FA50C06E9353Q37381549-8134A817-6086-4D68-BCCB-B4B5A04E055FQ38379767-4BBED05A-D2E7-4650-BC40-F6753C0B6240Q38793513-EEB89793-0DD8-43CB-9679-A05BDC3D8D64Q38935000-2CED36BE-FAC3-4FF0-A8EA-68080447A292Q39466706-15937AC6-2340-423F-AEE1-C6B867DB7432Q40002833-4803AEF7-84EE-4E29-A3E5-7CF681BF55D9Q41544232-9475E7F6-7A73-43E7-9E7D-0366FFCB4FE7Q42698900-7D3B0F22-8AA6-439E-A3E4-2038E661A598Q47400242-3CE926AE-29BF-4E34-9FC7-2A131728DB47Q47646496-02577C3B-7E7B-4334-9A8E-5DB8FC5882BEQ48121915-9EC51A49-903C-4EBF-92DD-D57458DE73A6Q50623134-55EDA87C-1F66-46BE-9D5E-6630A080535EQ53399264-ECBE7771-9AE0-4949-8BFF-F8622F7DBC44Q58553753-B8B9DF74-7E72-4858-9D16-4333E7106056
P2860
Old medications and new targeted therapies in systemic sclerosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Old medications and new targeted therapies in systemic sclerosis.
@ast
Old medications and new targeted therapies in systemic sclerosis.
@en
type
label
Old medications and new targeted therapies in systemic sclerosis.
@ast
Old medications and new targeted therapies in systemic sclerosis.
@en
prefLabel
Old medications and new targeted therapies in systemic sclerosis.
@ast
Old medications and new targeted therapies in systemic sclerosis.
@en
P2093
P2860
P356
P1433
P1476
Old medications and new targeted therapies in systemic sclerosis.
@en
P2093
Christopher P Denton
Dinesh Khanna
Vivek Nagaraja
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEU285
P577
2014-07-26T00:00:00Z